Glycogen Synthase Kinase 3 (GSK-3) influences epithelial barrier function by regulating Occludin, Claudin-1 and E-cadherin expression
- 2 July 2010
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 397 (3), 592-597
- https://doi.org/10.1016/j.bbrc.2010.05.164
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health Grants (DK55679, DK59888, DK72564, DK61379, DK79392)
This publication has 22 references indexed in Scilit:
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Role of Glycogen Synthase Kinase-3 in Cell Fate and Epithelial-Mesenchymal TransitionsCells Tissues Organs, 2007
- Claudin-1 regulates cellular transformation and metastatic behavior in colon cancerJCI Insight, 2005
- The second loop of occludin is required for suppression of Raf1-induced tumor growthOncogene, 2005
- Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcriptionThe Journal of cell biology, 2005
- Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transitionNature, 2004
- Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase‐3βThe FASEB Journal, 2002
- GSK3 takes centre stage more than 20 years after its discoveryBiochemical Journal, 2001
- The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expressionNature, 2000
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cellsNature, 2000